Photodynamic Therapy With HPPH in Treating Patients With Non-Small Cell Lung Cancer
Status:
Completed
Trial end date:
2004-10-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Photodynamic therapy uses light and drugs that make tumor cells more sensitive to
light to kill tumor cells. Photosensitizing drugs such as HPPH are absorbed by tumor cells
and, when exposed to light, become active and kill the tumor cells.
PURPOSE: Phase I trial to study the effectiveness of photodynamic therapy with HPPH in
treating patients who have non-small cell lung cancer.